Search results

• Ergotamine
  ==Drug uses== ...compared to the triptans, explain why ergotamine is a rarely used abortive drug for the treatment of migraines. The side effects include GI tract irritati
  7 KB (986 words) - 13:14, 20 September 2010
• Medetomidine
  ...|pmc=385445 |doi= |url=}}</ref> that can be administered as an intravenous drug solution with sterile water. It is currently approved for dogs in the Unite ...t sedative effects it is commonly used in more aggressive animals, where a drug/combination with a lesser effect (i.e. Acetylpromazine + an Opioid, an Opio
  6 KB (885 words) - 13:14, 20 September 2010
• Naphazoline
  ...It is a [[sympathomimetic]] agent with marked [[Adrenergic receptor|alpha adrenergic]] activity. It is a [[vasoconstrictor]] with a rapid action in reducing sw ...severe [[hypertension|hypertensive]] crisis if given a [[sympathomimetic]] drug such as naphazoline HCl
  3 KB (391 words) - 13:14, 20 September 2010
• Octopamine
  ...= Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | {{Adrenergic and dopaminergic agents}}
  7 KB (980 words) - 13:14, 20 September 2010
• Synephrine
  '''Synephrine''' (or '''oxedrine''') is a [[drug]] commonly used for weight loss. While its effectiveness is widely debated, * Phenylephrine acts primarily on alpha₁ [[adrenergic receptors]], so it has mainly vasoconstricting actions.
  7 KB (919 words) - 13:14, 20 September 2010
• Phenylephrine
  ...or '''Neo-Synephrine''' is an [[Alpha-1 adrenergic receptor|α₁-adrenergic receptor]] [[agonist]] used primarily as a [[decongestant]], as an agent to ..., or as eye drops. Phenylephrine is now the most common [[Over-the-counter drug|over-the-counter]] (OTC) [[decongestant]] in the United States; [[oxymetazo
  13 KB (1,712 words) - 13:15, 20 September 2010
• Phenylpropanolamine
  ...commonly used in [[prescription drug|prescription]] and [[over-the-counter drug|over-the-counter]] [[cough and cold preparation]]s. In [[veterinary medicin ...ncentrations are typically in the 50-300 µg/L range in persons taking the drug therapeutically, 300-3000 µg/L in abusers or poisoned patients and 2–50
  11 KB (1,420 words) - 13:15, 20 September 2010
• TDIQ
  ...discovery, pharmacological effects, and therapeutic potential |journal=CNS Drug Reviews |volume=13 |issue=4 |pages=405–22 |year=2007 |pmid=18078426 |doi= [[Category:Alpha-adrenergic agonists]]
  4 KB (449 words) - 13:15, 20 September 2010
• Oxymetazoline
  ...esults in [[vasoconstriction]]. In addition, the local application of the drug also results in vasoconstriction due to its action on endothelial postsynap The [[Food_and_Drug_Administration_(United_States)|Food and Drug Administration]] places oxymetazoline in [[pregnancy_category|category C]],
  6 KB (713 words) - 13:15, 20 September 2010
• Alpha-adrenergic agonist
  ...drug that selectively stimulates alpha [[adrenergic receptor]]s. The alpha-adrenergic receptor has two subclasses α₁ and α₂. {{Main|Alpha-1 adrenergic receptor#agonists}}
  4 KB (413 words) - 13:15, 20 September 2010
• (R)-3-Nitrobiphenyline
  ...ptor|α₂-adrenergic]] [[agonist]], selective for the [[Alpha-2C adrenergic receptor|α_2C]] subtype, as well as being a weak [[Antagonist (p [[Category:Alpha-adrenergic agonists]]
  2 KB (221 words) - 13:15, 20 September 2010
• BRL-44408
  ...as a selective [[Antagonist (pharmacology)|antagonist]] for the [[Alpha-2A adrenergic receptor|α_2A adrenoreceptor]].<ref name="pmid8387042">{{cite jo
  2 KB (195 words) - 13:16, 20 September 2010
• List of cutaneous conditions
  *[[Drug-induced ulcer of the lip]] *[[Drug-induced lipodystrophy]]
  177 KB (19,269 words) - 21:05, 21 September 2010
• Vasodilation
  | [[Adrenergic]] stimulation results in elevated levels of cAMP and [[protein kinase A]], | [[Noradrenaline]] || [[Beta-2 adrenergic receptor|β-2 adrenergic receptor]]
  13 KB (1,665 words) - 21:28, 21 September 2010
• Cannabinoid
  ...e journal |author=Lambert DM, Fowler CJ |title=The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications |journal=J. ...pbell, VA. "Phytocannabinoids, CNS cells and development: A dead issue?" ''Drug and Alcohol Review''. 2010 Jan;29(1):91-98. PMID 20078688</ref> To the righ
  49 KB (6,487 words) - 22:06, 21 September 2010
• Kratom
  ...am, and in southern regions, thom. In addition to being used as a narcotic drug in its own right, it is often used as a substitute for opium when opium is .... In lower dosages, mitragynine exhibits a yohimbine-like binding to alpha-adrenergic receptors, as well as some binding to the delta opioid receptors. As doses
  17 KB (2,570 words) - 22:07, 21 September 2010
• Cannabigerol
  ...bis'' with high [[tetrahydrocannabinol|THC]] content (the kind used as a [[drug]]). ...affinity_(pharmacology)|affinity]] [[a2-adrenergic receptor|α₂-adrenergic receptor]] [[agonist]], moderate affinity [[5-HT1A receptor|5-HT<sub>1A</su
  3 KB (361 words) - 22:08, 21 September 2010
• Cholinergic
  == Cholinergic drug == {{Main|Parasympathomimetic drug}}
  3 KB (374 words) - 22:11, 21 September 2010
• HCN channel
  ...tal cortex known as the alpha2A-adrenoceptor (also known as the [[alpha-2A adrenergic receptor]]) has been shown to improve [[working memory]], or the brain’s ...themselves. By directly inhibiting HCN channels in vitro, either with the drug ZD7288 or viral knockdown of [[HCN1]] expression, the Arnsten lab was able
  8 KB (1,157 words) - 22:12, 21 September 2010
• Signal transduction
  ...l KM, McGraw DW and Liggett SB.|title=Pharmacology and physiology of human adrenergic receptor polymorphisms|journal=Annu Rev Pharmacol Toxicol|year=2003|volume= ...ric [[G protein]]).&nbsp; Many receptors make up this family, including [[adrenergic receptor]]s, neurotransmitter receptors, [[olfactory receptor]]s, [[opioid
  55 KB (7,677 words) - 22:12, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)